{"product_id":"uw-medicine-comprehensive-hematology-oncology-review-2024","title":"UW Medicine Comprehensive Hematology \u0026 Oncology Review 2024","description":"\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eUW Medicine Comprehensive Hematology \u0026amp; Oncology Review 2024\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e Include: 54 videos + 55 pdfs, size: 40.3 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Target Audience: physicians, advanced practice providers, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location: Monday, September 23, 2024, 7:15 AM – Friday, September 27, 2024, 5:00 PM, Other, Seattle, WA\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Hematology, Oncology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Non-Physician, Nurse, Nurse Practitioner, Physician, Physician Associate\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eOverview\u003c\/div\u003e\n\u003cp\u003eThis 54-topic program covers data supporting guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and hematologic disorders. After completing the program, learners will have a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors, hematologic disorders and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.. The material can be used to help prepare attendees for certifying and re-certifying exams.\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.\u003c\/li\u003e\n\u003cli\u003eExplain the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.\u003c\/li\u003e\n\u003cli\u003eIntegrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.\u003c\/li\u003e\n\u003cli\u003eOrganize new therapeutic and diagnostic approaches into clinical practice as appropriate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"Grid__row___qCQ9V Grid__small___AMx35\"\u003e\n\u003cdiv class=\"Grid__column___NWQ7M Grid__col_12___pjiIR Grid__small___AMx35\"\u003e\n\u003cdiv id=\"widget:853a10bf-075a-489b-a235-12a4d6a3784f\" class=\"Content__widgetIdcontainer___1ace\" data-cvent-id=\"widget-content-NucleusText\"\u003e\n\u003cdiv class=\"Text__container___g_YuZ expanded\" data-cvent-id=\"widget-NucleusText-widget:853a10bf-075a-489b-a235-12a4d6a3784f\"\u003e\n\u003cdiv class=\"slight css-87ndg2\"\u003e\n\u003cdiv class=\"css-vsf5of\"\u003e\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eIntended Audience:\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"Grid__row___qCQ9V Grid__small___AMx35\"\u003e\n\u003cdiv class=\"Grid__column___NWQ7M Grid__col_12___pjiIR Grid__small___AMx35\"\u003e\n\u003cdiv id=\"widget:522948b8-693e-4f43-880d-1d3246364883\" class=\"Content__widgetIdcontainer___1ace\" data-cvent-id=\"widget-content-NucleusText\"\u003e\n\u003cdiv class=\"Text__container___g_YuZ expanded\" data-cvent-id=\"widget-NucleusText-widget:522948b8-693e-4f43-880d-1d3246364883\"\u003e\n\u003cdiv class=\"css-87ndg2\"\u003e\n\u003cdiv class=\"css-vsf5of\"\u003e\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eThis educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAcute Lymphoblastic Leukemia.mp4\u003cbr\u003eAcute Lymphoblastic Leukemia.pdf\u003cbr\u003eAcute Myeloid Leukemia.mp4\u003cbr\u003eAcute Myeloid Leukemia.pdf\u003cbr\u003eAdjuvant Therapy for Breast Cancer.mp4\u003cbr\u003eAdjuvant Therapy for Breast Cancer.pdf\u003cbr\u003eAnal Cancer.mp4\u003cbr\u003eAnal Cancer.pdf\u003cbr\u003eB-NHL, Aggressive Non-Hodgkin Lymphoma.mp4\u003cbr\u003eB-NHL, Aggressive Non-Hodgkin Lymphoma.pdf\u003cbr\u003eB-NHL, Indolent Non-Hodgkin Lymphoma.mp4\u003cbr\u003eB-NHL, Indolent Non-Hodgkin Lymphoma.pdf\u003cbr\u003eBenign White Cell Disorders.mp4\u003cbr\u003eBenign White Cell Disorders.pdf\u003cbr\u003eBladder Cancer.mp4\u003cbr\u003eBladder Cancer.pdf\u003cbr\u003eBleeding Disorders.mp4\u003cbr\u003eBleeding Disorders.pdf\u003cbr\u003eCholangiocarcinoma.mp4\u003cbr\u003eCholangiocarcinoma.pdf\u003cbr\u003eChronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) \u0026amp; Hairy Cell Leukemia.mp4\u003cbr\u003eChronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) \u0026amp; Hairy Cell Leukemia.pdf\u003cbr\u003eChronic Myeloid Leukemia.mp4\u003cbr\u003eChronic Myeloid Leukemia.pdf\u003cbr\u003eCNS Cancers.mp4\u003cbr\u003eCNS Cancers.pdf\u003cbr\u003eColorectal Cancer.mp4\u003cbr\u003eColorectal Cancer.pdf\u003cbr\u003eConsultative Hematology.mp4\u003cbr\u003eConsultative Hematology.pdf\u003cbr\u003eEsophageal Gastric Cancer.mp4\u003cbr\u003eEsophageal Gastric Cancer.pdf\u003cbr\u003eFamilial Syndromes.mp4\u003cbr\u003eFamilial Syndromes.pdf\u003cbr\u003eGastrointestinal Neuroendocrine Tumors.mp4\u003cbr\u003eGastrointestinal Neuroendocrine Tumors.pdf\u003cbr\u003eGynecologic Oncology – Cervical and Endometrial Cancers.mp4\u003cbr\u003eGynecologic Oncology – Cervical and Endometrial Cancers.pdf\u003cbr\u003eGynecologic Oncology – Ovarian Cancer.mp4\u003cbr\u003eGynecologic Oncology – Ovarian Cancer.pdf\u003cbr\u003eHead, Neck and Thyroid Cancer.mp4\u003cbr\u003eHead, Neck and Thyroid Cancer.pdf\u003cbr\u003eHematology Pharmacology Pearls.mp4\u003cbr\u003eHematology Pharmacology Pearls.pdf\u003cbr\u003eHematopoietic Cell Transplantation.mp4\u003cbr\u003eHematopoietic Cell Transplantation.pdf\u003cbr\u003eHepatocellular Cancer.mp4\u003cbr\u003eHepatocellular Cancer.pdf\u003cbr\u003eHodgkin Lymphoma.mp4\u003cbr\u003eHodgkin Lymphoma.pdf\u003cbr\u003eInfectious Disease Complications.mp4\u003cbr\u003eInfectious Disease Complications.pdf\u003cbr\u003eInherited \u0026amp; Acquired Marrow Failure.mp4\u003cbr\u003eInherited \u0026amp; Acquired Marrow Failure.pdf\u003cbr\u003eIntegrative Medicine.mp4\u003cbr\u003eIntegrative Medicine.pdf\u003cbr\u003eIron Metabolism Disorders \u0026amp; Hemolytic Anemias.mp4\u003cbr\u003eIron Metabolism Disorders \u0026amp; Hemolytic Anemias.pdf\u003cbr\u003eMelanoma and other Skin Cancers.mp4\u003cbr\u003eMelanoma and other Skin Cancers.pdf\u003cbr\u003eMesothelioma.mp4\u003cbr\u003eMesothelioma.pdf\u003cbr\u003eMetastatic Breast Cancer.mp4\u003cbr\u003eMetastatic Breast Cancer.pdf\u003cbr\u003eMOC Questions.pdf\u003cbr\u003eMyelodysplastic Syndromes.mp4\u003cbr\u003eMyelodysplastic Syndromes.pdf\u003cbr\u003eMyeloproliferative Neoplasms.mp4\u003cbr\u003eMyeloproliferative Neoplasms.pdf\u003cbr\u003eNewly-Diagnosed Myeloma.mp4\u003cbr\u003eNewly-Diagnosed Myeloma.pdf\u003cbr\u003eNon-Small Cell Lung Cancer – Adjuvant Locally Advanced.mp4\u003cbr\u003eNon-Small Cell Lung Cancer – Adjuvant Locally Advanced.pdf\u003cbr\u003eNon-Small Cell Lung Cancer – Metastatic.mp4\u003cbr\u003eNon-Small Cell Lung Cancer – Metastatic.pdf\u003cbr\u003ePancreatic Cancer.mp4\u003cbr\u003ePancreatic Cancer.pdf\u003cbr\u003eProstate Cancer.mp4\u003cbr\u003eProstate Cancer.pdf\u003cbr\u003eRadiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative].mp4\u003cbr\u003eRadiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative].pdf\u003cbr\u003eRelapsed Refractory Myeloma \u0026amp; Amyloidosis.mp4\u003cbr\u003eRelapsed Refractory Myeloma \u0026amp; Amyloidosis.pdf\u003cbr\u003eRenal Cell Carcinoma.mp4\u003cbr\u003eRenal Cell Carcinoma.pdf\u003cbr\u003eSarcoma.mp4\u003cbr\u003eSarcoma.pdf\u003cbr\u003eSmall Cell Lung Cancer.mp4\u003cbr\u003eSmall Cell Lung Cancer.pdf\u003cbr\u003eSmoldering Myeloma \u0026amp; MGUS.mp4\u003cbr\u003eSmoldering Myeloma \u0026amp; MGUS.pdf\u003cbr\u003eSolid Tumor Pharmacology Pearls.mp4\u003cbr\u003eSolid Tumor Pharmacology Pearls.pdf\u003cbr\u003eSupportive Care.mp4\u003cbr\u003eSupportive Care.pdf\u003cbr\u003eT-Cell Lymphoma – NHL.mp4\u003cbr\u003eT-Cell Lymphoma – NHL.pdf\u003cbr\u003eTesticular Cancer.mp4\u003cbr\u003eTesticular Cancer.pdf\u003cbr\u003eThalassemia \u0026amp; Hemoglobinopathies.mp4\u003cbr\u003eThalassemia \u0026amp; Hemoglobinopathies.pdf\u003cbr\u003eTherapy for Non-Invasive Breast Cancer.mp4\u003cbr\u003eTherapy for Non-Invasive Breast Cancer.pdf\u003cbr\u003eThrombocytopenia.mp4\u003cbr\u003eThrombocytopenia.pdf\u003cbr\u003eThrombosis \u0026amp; Anticoagulation.mp4\u003cbr\u003eThrombosis \u0026amp; Anticoagulation.pdf\u003cbr\u003eTransfusion Medicine.mp4\u003cbr\u003eTransfusion Medicine.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":" Ambossle","offers":[{"title":"Default Title","offer_id":46548742340833,"sku":"","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0750\/1925\/6033\/files\/UW.jpg?v=1749836420","url":"https:\/\/ambosslee.com\/products\/uw-medicine-comprehensive-hematology-oncology-review-2024","provider":" Ambosslee","version":"1.0","type":"link"}